CRP and lung carcinoma: In multiple tumors, including lung cancer, inflammatory markers such as C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in peripheral blood have been reported to be significantly correlated with patient prognosis3–8.